Tuttle Capital Management’s Pfizer PFE Stock Holding History

Tuttle Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-25,092	Closed	-$983K	–	231
2021 Q2	$983K	Buy	+25,092	New	+$976K	0.43%	78
2021 Q1	–	Sell	-27,072	Closed	-$997K	–	293
2020 Q4	$997K	Buy	27,072 +18,177	+204%	+$667K	0.77%	25
2020 Q3	$310K	Buy	+8,895	New	+$312K	0.21%	96
2019 Q1	–	Sell	-34,814	Closed	-$1.44M	–	194
2018 Q4	$1.44M	Buy	+34,814	New	+$1.45M	0.55%	58
2017 Q1	–	Sell	-11,095	Closed	-$341K	–	58
2016 Q4	$341K	Buy	+11,095	New	+$339K	0.34%	34
2016 Q3	–	Sell	-3,481	Closed	-$117K	–	74
2016 Q2	$117K	Buy	+3,481	New	+$111K	0.11%	45

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Tuttle Capital Management's PFE Position: Q3 2021 in Review

Tuttle Capital Management sold out of Pfizer (PFE) in Q3 2021, closing a stake of 25,092 shares — an estimated $983K sold.

Tuttle Capital Management first reported a position in PFE in Q2 2016 and held it in 6 quarters. The position peaked at $1.44M in Q4 2018. 2,803 funds tracked by Wall St. Rank hold PFE as of Q3 2021.

Tuttle Capital Management reported no remaining Pfizer position as of Q3 2021 after selling out during the quarter.
Tuttle Capital Management sold 25,092 Pfizer shares in Q3 2021, an estimated $983K.
Tuttle Capital Management first reported a position in Pfizer in Q2 2016 and held it in 6 quarters.
Tuttle Capital Management's Pfizer position peaked at $1.44M in Q4 2018.
2,803 funds tracked by Wall St. Rank held Pfizer as of Q3 2021.

Based on Tuttle Capital Management's 13F filing for Q3 2021, filed 20 Oct 2021.